HeartMate 3 in Patients with Extracorporeal Life Support: Improved Outcomes over Previous Devices and Comparable to Transplantation?
Three-Year Results of the ECSL Registry in Extracorporeal Life Support Patients Receiving HM3 Implants from January 2016 to April 2022 Across 14 Centers, Compared to Other Long-Term Devices.